UNUM Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
UNUM Therapeutics Inc
TickerCOGT
CIK #0001622229
CUSIP19241Q101
SectorLife Sciences - Pharmaceutical Preparations
Address200 Cambridge Park Drive Suite 3100, Cambridge, MA 02140
Source [EDGAR]
CIK Filing 2011 - 2025
[0001622229] 10-K
[0001622229] 10-Q
[0001622229] 3
[0001622229] 4
[0001622229] 8-K
[0001622229] D
[0001622229] SC 13D
[0001622229] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Commodore Capital LP Cogent Biosciences Inc [2025-08-14] 0.0
Flynn James E Cogent Biosciences Inc [2025-07-11] 0.0
Paradigm Biocapital Advisors LP Cogent Biosciences Inc [2025-02-12] 0.0
Kynam Capital Management LP Cogent Biosciences Inc [2024-02-14] 6.8
Vanguard Group Inc Cogent Biosciences Inc [2024-02-13] 5.27
FMR LLC Cogent Biosciences Inc [2024-02-09] 0.0
Suvretta Capital Management LLC Cogent Biosciences Inc [2024-02-05] 6.4
Point72 Asset Management LP Cogent Biosciences Inc [2023-06-01] 5.0
State Street Corp Cogent Biosciences Inc [2023-02-03] 6.1
BlackRock Inc Cogent Biosciences Inc [2023-02-03] 7.1
RA Capital Management LP Cogent Biosciences Inc [2022-09-06] 5.49
BlackRock Inc Cogent Biosciences Inc [2022-07-08] 3.8
Flynn James E Cogent Biosciences Inc [2022-06-17] 9.64
Frazier Life Sciences Public Fund LP Cogent Biosciences Inc [2022-03-01] 5.5
Biotechnology Value Fund L P Cogent Biosciences Inc [2022-02-14] 4.2
Eventide Asset Management LLC Cogent Biosciences Inc [2022-02-14] 8.8
Janus Henderson Group PLC Cogent Biosciences Inc [2022-02-11] 6.3
BlackRock Inc Cogent Biosciences Inc [2022-02-04] 6.8
Commodore Capital LP Cogent Biosciences Inc [2021-11-04] 5.4
TCG Crossover Management LLC Cogent Biosciences Inc [2021-07-08] 5.2
RTW Investments LP Cogent Biosciences Inc [2020-12-03] 0.99
Ally Bridge Group NY LLC Cogent Biosciences Inc [2020-11-19] 8.03
Logos Global Management LP UNUM Therapeutics Inc [2020-09-08] 5.0
Venrock Healthcare Capital Partners II LP UNUM Therapeutics Inc [2020-07-20] 5.0
Biotechnology Value Fund L P UNUM Therapeutics Inc [2020-07-16] 0.99
Ridgeback Capital Investments LP UNUM Therapeutics Inc [2020-07-16] 6.2
Fairmount Funds Management LLC UNUM Therapeutics Inc [2020-07-10] 19.99
New Leaf Ventures III LP UNUM Therapeutics Inc [2019-02-13] 3.0
Sanofi UNUM Therapeutics Inc [2019-02-11] 5.91
BlackRock Inc UNUM Therapeutics Inc [2019-02-08] 5.1
Atlas Venture Fund IX LP UNUM Therapeutics Inc [2019-02-08] 11.21
FMR LLC UNUM Therapeutics Inc [2018-04-05] 0.0
Form 3/4/5 Filer 2011 - 2025
Cogent Biosciences, Inc.
Fairmount Funds Management LLC
Ferrante Karen Jean
Shegog Todd
Morris Arlene
Harwin Peter Evan
Cain Christopher W
Ros Matthew
Robinson John Edward
Kearns Evan
Robbins Andrew R
Green John L.
Pinnow Cole
Sachs Jessica
Campana Dario
Shah Nimish P
VHCP Co-Investment Holdings II, LLC
Koh Bong Y
Venrock Healthcare Capital Partners III, L.P.
VHCP Management II, LLC
VHCP Co-Investment Holdings III, LLC
VHCP Management III, LLC
Venrock Healthcare Capital Partners II, L.P.
Booth Bruce
Aldag Jorn
Ettenberg Seth
Osborne Matthew Scott
Hodge Geoffrey
Perez Robert J
Ratcliffe Liam
Vasconcelles Michael
Wilson Charles
FMR LLC
FIL Ltd
Atlas Venture Associates IX, L.P.
Atlas Venture Fund IX, L.P.
Atlas Venture Associates IX, LLC
Stamoulis Christiana
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2025-06-30] DFND 17,076,152 17,078,468
Paradigm Biocapital Advisors LP [2025-06-30] SOLE 10,352,449 10,352,449
BlackRock, Inc. [2025-06-30] SOLE 8,470,344 8,626,581
Kynam Capital Management LP [2025-06-30] SOLE 8,492,557 8,492,557
TCG Crossover Management LLC [2025-06-30] SOLE 6,964,375 6,964,375
Vanguard Group Inc [2025-06-30] SOLE 0 6,321,276
Fairmount Funds Management LLC [2025-06-30] SOLE 6,225,641 6,225,641
Point72 Asset Management LP [2025-06-30] DFND 0 4,911,924
VR Adviser LLC [2025-06-30] SOLE 4,755,411 4,755,411
UBS Group AG [2025-06-30] DFND 3,518,671 3,518,671
State Street Corp [2025-06-30] DFND 3,122,173 3,371,912
Vestal Point Capital LP [2025-06-30] SOLE 3,080,000 3,080,000
Sofinnova Investments Inc [2025-06-30] SOLE 3,015,505 3,015,505
Janus Henderson Group PLC [2025-06-30] DFND 0 2,873,053
Octagon Capital Advisors LP [2025-06-30] SOLE 2,763,000 2,763,000
Geode Capital Management LLC [2025-06-30] DFND 2,672,113 2,672,113
Deerfield Management Company LP [2025-06-30] DFND 2,640,215 2,640,215
Commodore Capital LP [2025-06-30] SOLE 2,311,164 2,311,164
Saturn V Capital Management LP [2025-06-30] SOLE 2,297,524 2,297,524
Caption Management LLC [2025-06-30] SOLE 2,216,128 2,216,128
Frazier Life Sciences Management LP [2025-06-30] SOLE 1,734,601 1,734,601
Nantahala Capital Management LLC [2025-06-30] SOLE 1,655,689 1,655,689
Redmile Group LLC [2025-06-30] SOLE 1,448,040 1,448,040
Emerald Advisers LLC [2025-06-30] SOLE 1,028,238 1,445,774
Bank of America Corp /DE/ [2025-06-30] DFND 20,480 1,400,965
Ikarian Capital LLC [2025-06-30] SOLE 1,298,128 1,298,128
Morgan Stanley [2025-06-30] DFND 1,207,359 1,229,121
Goldman Sachs Group Inc [2025-06-30] DFND 1,200,072 1,200,437
Vivo Capital LLC [2025-06-30] SOLE 1,122,471 1,122,471
Millennium Management LLC [2025-06-30] SOLE 969,973 1,046,873
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com